Some Cap-Equipment Vendors Cautious on Pharma s Fourth-Quarter Spending Plans | GenomeWeb

Spending by pharmaceutical companies on life-science research tools appears to be slowly improving as the year nears its conclusion, and that improvement is expected to continue through the fourth quarter, according to industry observers and executives of several firms selling instruments to the pharma market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.